226. 間質性膀胱炎（ハンナ型） Interstitial cystitis with Hunners ulcer Clinical trials / Disease details

臨床試験数 : 143 / 薬物数 : 171 - (DrugBank : 56) / 標的遺伝子数 : 64 - 標的パスウェイ数 : 145

7 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05275647 (ClinicalTrials.gov)	May 18, 2021	13/1/2022	Efficacy and Safety of Low Energy Shock Wave Plus BotulinumToxin A in Treating Patients With Interstitial Cystitis	Therapeutic Efficacy and Safety of Low Energy Shock Wave (LESW) Plus Botulinum Toxin A Instillation in Treatment of Patients With Interstitial Cystitis Refractory to Conventional Therapy - A Clinical and Immunohistochemistry Study	Interstitial Cystitis	Drug: BOTOX 100U in normal saline;Drug: Normal saline	Buddhist Tzu Chi General Hospital	Ministry of Science and Technology, Taiwan;Hualien Tzu Chi General Hospital	Recruiting	20 Years	N/A	All	75	Phase 2	Taiwan
2	NCT01393223 (ClinicalTrials.gov)	July 21, 2015	7/7/2011	Evaluation of Intravesical LP08 in Patients With Interstitial Cystitis/Painful Bladder Syndrome	A Single-Center, Double-Blind, Randomized, Dose-Ranging, Placebo Controlled Trial Comparing the Safety, Tolerability and Efficacy of LP-08 With Placebo in Subjects With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)	Interstitial Cystitis	Drug: LP-08 80mg;Drug: Normal saline;Drug: LP-08 20mg	Lipella Pharmaceuticals, Inc.	William Beaumont Hospitals	Completed	18 Years	70 Years	All	21	Phase 2	United States
3	NCT02247557 (ClinicalTrials.gov)	September 2014	15/9/2014	Intravesical Instillation of Liposome Encapsulated Botulinum Toxin A (Lipotoxin) in Treatment of Interstitial Cystitis	Intravesical Instillation of Liposome Encapsulated Botulinum Toxin A (Lipotoxin) in Treatment of Interstitial Cystitis — a Randomized, Double-blind, Placebo-controlled, Prospective Study	Interstitial Cystitis	Drug: Liposome encapsulated BoNT-A;Drug: BOTOX 200U in normal saline;Drug: Normal saline	Buddhist Tzu Chi General Hospital	NULL	Completed	20 Years	80 Years	All	90	Phase 2	Taiwan
4	NCT01969773 (ClinicalTrials.gov)	December 2012	22/10/2013	Intravesical Botulinum Toxin A Injections in Treatment of Interstitial Cystitis Refractory to Conventional Treatment	Intravesical Botulinum Toxin A Injection in Treatment of Interstitial Cystitis Refractory to Conventional Treatment - A Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial	Interstitial Cystitis	Drug: Botulinum toxin A;Drug: Normal saline instillation	Buddhist Tzu Chi General Hospital	NULL	Completed	20 Years	85 Years	All	60	Phase 2	Taiwan
5	NCT01195116 (ClinicalTrials.gov)	May 2010	13/8/2010	Usefulness of Dexmedetomidine on Post-operative Pain Management in Patients With Interstitial Cystitis	Usefulness of Dexmedetomidine on Post-operative Pain Management in Patients With Interstitial Cystitis	Interstitial Cystitis	Drug: Dexmedetomidine;Drug: Normal Saline	University of Rochester	NULL	Completed	18 Years	N/A	All	41	Phase 4	United States
6	NCT00823030 (ClinicalTrials.gov)	January 2009	14/1/2009	Effect of Intravesical Lidocaine on Urodynamic and Symptomatic Parameters of Interstitial Cystitis	Effect of Intravesical Lidocaine on Urodynamic and Symptomatic Parameters of Interstitial Cystitis	Interstitial Cystitis	Procedure: Urodynamic study;Drug: Lidocaine;Other: Normal Saline	North Shore Long Island Jewish Health System	NULL	Withdrawn	18 Years	80 Years	Both	0	N/A	United States
7	NCT00194610 (ClinicalTrials.gov)	May 2004	13/9/2005	Botox as a Treatment for Interstitial Cystitis in Women	Botox (Botulinum Toxin A) as a Treatment for Interstitial Cystitis in Women: A Randomized Placebo Controlled Trial	Painful Bladder Syndrome;Interstitial Cystitis	Drug: Botox;Other: normal saline	University of Washington	Paul G. Allen Family Foundation	Completed	18 Years	N/A	Female	20	Phase 4	United States

先頭へ